We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
649
Reduced
1,111
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoDaddy
GDDY
|
+$83M |
| 2 |
Morgan Stanley
MS
|
+$67.7M |
| 3 |
Structure Therapeutics
GPCR
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$63.8M |
| 5 |
Kenvue
KVUE
|
+$60.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$207M |
| 2 |
Williams Companies
WMB
|
+$150M |
| 3 |
Verizon
VZ
|
+$128M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$123M |
| 5 |
Cisco
CSCO
|
+$93.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.22% |
| 2 | Technology | 16.21% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Braze
BRZE
$3.02B
| $26.8M | 0.07% |
503,994
+239,742
| +91% | +$11.9M |
|
327
Qorvo
QRVO
$7.9B
| $26.7M | 0.07% |
237,251
+21,093
| +10% | +$2.04M |
|
328
Jackson Financial
JXN
$8.4B
| $26.7M | 0.07% |
521,266
+192,995
| +59% | +$8.49M |
|
|
DCBO
329
Docebo
DCBO
$559M
| $26.6M | 0.07% |
549,449
| – | – |
|
330
A.O. Smith
AOS
$8.55B
| $26.3M | 0.07% |
318,893
+1,569
| +0.5% | +$116K |
|
331
Alnylam Pharmaceuticals
ALNY
$38.3B
| $26.3M | 0.07% |
+137,141
| New | +$23.4M |
|
332
General Motors
GM
$80.9B
| $26.2M | 0.07% |
730,029
+78,938
| +12% | +$2.44M |
|
333
Citigroup
C
$213B
| $26.2M | 0.06% |
508,471
-109,620
| -18% | -$4.85M |
|
334
Biogen
BIIB
$30.9B
| $25.9M | 0.06% |
100,148
-4,320
| -4% | -$1.06M |
|
335
Bio-Rad Laboratories Class A
BIO
$8.76B
| $25.7M | 0.06% |
79,490
+17,762
| +29% | +$5.57M |
|
336
Power Integrations
POWI
$3.15B
| $25.5M | 0.06% |
311,010
+2,985
| +1% | +$229K |
|
337
SBA Communications
SBAC
$19.8B
| $25.5M | 0.06% |
100,600
-27,016
| -21% | -$6.07M |
|
338
Intercontinental Exchange
ICE
$87.2B
| $25.3M | 0.06% |
196,745
-927
| -0.5% | -$105K |
|
339
General Mills
GIS
$20.2B
| $25M | 0.06% |
384,416
-38,764
| -9% | -$2.5M |
|
340
Nike
NKE
$64.1B
| $24.9M | 0.06% |
228,973
-98,115
| -30% | -$10.5M |
|
341
Vaxcyte
PCVX
$7.65B
| $24.8M | 0.06% |
394,192
-1,615
| -0.4% | -$83.9K |
|
|
NVO
342
Novo Nordisk
NVO
$228B
| $24.7M | 0.06% |
238,828
-5,988
| -2% | -$592K |
|
343
Guardant Health
GH
$19.1B
| $24.5M | 0.06% |
907,200
-202,300
| -18% | -$5.31M |
|
344
MYR Group
MYRG
$5.01B
| $24.5M | 0.06% |
169,319
-1,359
| -0.8% | -$175K |
|
345
TD Synnex
SNX
$19.9B
| $24.4M | 0.06% |
227,045
-127,573
| -36% | -$12.5M |
|
346
Parker-Hannifin
PH
$120B
| $24.3M | 0.06% |
52,740
+12,398
| +31% | +$5.16M |
|
347
CAVA Group
CAVA
$7.61B
| $24.3M | 0.06% |
565,054
+115,054
| +26% | +$4.01M |
|
348
IBM
IBM
$213B
| $24.1M | 0.06% |
147,493
-415,039
| -74% | -$62.7M |
|
349
HCA Healthcare
HCA
$90.6B
| $23.9M | 0.06% |
88,472
+1,153
| +1% | +$285K |
|
350
Mastercard
MA
$498B
| $23.8M | 0.06% |
55,823
-43,372
| -44% | -$17.4M |
|
Similar funds
Federated Hermes's Q4 2023 Portfolio in Review
As of Q4 2023, Federated Hermes held 2,266 positions worth $40.3B, up 7.3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes withdrew a net $1.55B in Q4 2023, closing 232 positions and reducing 1,111 holdings. Its most notable exit was Splunk Inc, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Zscaler worth $39.2M.
- Federated Hermes's largest Q4 2023 buy was Zscaler: 177,136 shares worth $39.2M.
- Federated Hermes added most to GoDaddy in Q4 2023, an estimated $83M increase.
- Federated Hermes's biggest Q4 2023 reduction was Amgen, cutting an estimated $207M.
- Federated Hermes fully exited Splunk Inc in Q4 2023, selling an estimated $123M.
- Federated Hermes's ten largest holdings make up 14% of its $40.3B portfolio in Q4 2023.
- Federated Hermes opened 182 new positions and closed 232 in Q4 2023.
- Federated Hermes's portfolio value rose 7.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.